#clinicaltrials #GMP #temperaturemapping #coldchain #CTU #investigationalmedicinalproduct #regulatorycompliance @medresearchnews Tag

The integrity of an investigational medicinal product at the point it reaches a clinical trial subject is the silent foundation on which the entire trial rests. If the product has been stored outside its specified temperature range at any point between manufacture and administration, its potency, safety profile, or both may be compromised. The resulting data may no longer accurately reflect the product as it was intended to be tested. The regulatory, scientific, and patient safety implications of that failure are significant, which is why controlled-temperature unit qualification is not an administrative exercise — it is a precondition for trustworthy clinical science. According to the US Food and Drug Administration, current Good Manufacturing Practice regulations require that storage conditions for drug products be controlled, monitored, and documented to ensure product quality — a requirement that applies to investigational products used in clinical trials.

[caption id="attachment_76195" align="aligncenter" width="500"]Controlled-Temperature Unit Qualification Image by sergeysushitskyi on Magnific[/caption]